(Q34132872)
Statements
1 reference
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial (English)
1 reference
Benedikte Hasselbalch
1 reference
Mats Holmberg
1 reference
Michael Kosteljanetz
1 reference
Helle Broholm
1 reference
Marie-Thérése Stockhausen
1 reference
Hans Skovgaard Poulsen
1 reference
5 February 2010
1 reference
1 reference
12
1 reference
508-516
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference